Application 203624
- Type
- ANDA
- Sponsor
- MYLAN INSTITUTIONAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACETYLCYSTEINE | ACETYLCYSTEINE | INJECTABLE;INTRAVENOUS | 6GM/30ML (200MG/ML) | No | No |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | ea99ee380514… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A203624-001 | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE / INTRAVENOUS | 2015-06-19 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetylcysteine | ACETYLCYSTEINE | Hospira, Inc. | 5558a5f5-e821-473b-7d8a-5d33d09f0586 | 2026-05-22 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Glenmark Pharmaceuticals Inc., USA | f811ddfc-d7c1-4637-ae81-80c38a77cb80 | 2026-05-06 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Somerset Therapeutics, LLC | d50c8ab6-26f8-4669-89d1-c4d26698159a | 2026-04-11 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Cardinal Health 107, LLC | c90fca12-12fb-4cf6-bd6f-83bc0d95df81 | 2026-04-07 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Eugia US LLC | 5ae53725-1abb-4122-9c85-f26c2c31566c | 2025-12-02 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Sagent Pharmaceuticals | c206c659-16ea-444a-8c60-8a3343400ada | 2025-10-26 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | ONESOURCE SPECIALTY PHARMA LIMITED | 3b0310d2-4e70-4b94-8d69-cb5999a32b54 | 2025-09-12 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Hikma Pharmaceuticals USA Inc. | 277963a0-8ab2-4305-a688-28e47e87c584 | 2025-09-09 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Cameron Pharmaceuticals | 8165ad85-98e7-438f-9567-5cfda88d0ebf | 2025-08-26 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| acetylcysteine | ACETYLCYSTEINE | Padagis US LLC | 9d305722-e74f-4f48-8d2c-0daa99144749 | 2025-07-31 | Warnings, Adverse reactions | acetylcysteine ACETYLCYSTEINE |
| ACETADOTE | ACETYLCYSTEINE | Cumberland Pharmaceuticals Inc. | 472f158a-5ab9-4308-8e49-1116e6ea3d39 | 2025-04-30 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | American Regent, Inc. | f56b4087-db48-4fd7-84ec-9c927962b805 | 2024-12-17 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 75b48fab-cef6-465c-a1e0-d085b3988bc4 | 2024-08-15 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Somerset Therapeutics, LLC | b8d3ed96-d7ee-43f4-986c-a7d04808711a | 2024-06-13 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Xellia Pharmaceuticals USA LLC | 3e2e187e-2445-43b1-b66c-b828e2adf022 | 2023-05-31 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 8cca4e4c-85a2-d575-e053-2995a90a6599 | 2022-10-31 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | d990ef51-ced2-4359-b99b-092334d2dc9b | 2022-10-31 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 8d81039e-20ef-5144-e053-2a95a90a89fd | 2022-10-31 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Sagent Pharmaceuticals | 2324d60b-4f49-4759-a46e-a06bfce7e8aa | 2022-04-05 | Warnings, Adverse reactions | Acetylcysteine ACETYLCYSTEINE |
| ACETYLCYSTEINE | ACETYLCYSTEINE | Indoco Remedies Limited | 6588c28d-0515-4cdf-99d3-c4ad3fd0976c | 2022-03-01 | Warnings, Adverse reactions | ACETYLCYSTEINE ACETYLCYSTEINE |